Clinical trial
Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
NCT00473720 · Yale University, Other · Completed
Key facts
| NCT number | NCT00473720 |
|---|---|
| Title | Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers |
| Official title | Phase I Dose Finding Study of the Orally Bioavailable Platinum Analog Satraplatin in Combination With Abraxane (Paclitaxel Protein-bound Particles) in Advanced Cancers |
| Lead sponsor | Yale University, Other |
| Collaborators | Agennix Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Cancers |
| Intervention type | Drug |
| Interventions | Satraplatin, Abraxane |
| Enrollment | 15 |
| Start date | May 1, 2007 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | May 15, 2007 |
| Last update posted | Jan 23, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: